alias:: Endolymphatic hydrops, Meniere's Disease
ICD-11_Code:: AB30.1
tags:: disease, ent

- #definition Ménière's Disease is a chronic disorder of inner ear where the endolymphatic system is distended with endolymph & characterized by episodic vertigo, sensorineural hearing loss, tinnitus & a sense of aural fullness.  #ent-prof-card #ent-prof-written #card
  id:: 6756c23f-2e59-47e9-b177-c10af5c95e12
  deck:: #ENT
- ## Etiology
  background-color:: blue
	- ### Causative Agents
	  *Exact cause unknown*
		- Possible autoimmune, viral or genetic factors
	- ### Risk Factors
		- Age (40-60 years)
		- Family history
		- Migraine
		- Autoimmune disorders
		- Head trauma
- ## Epidemiology
  background-color:: blue
	- ### Incidence
		- ~5-50 cases per 100k annually
	- ### Prevalence
		- 0.2% of population
		- ### Demographics
			- age : More common in adults (40-60 years)
			- sex : Slightly female predominance
	- ### Geographic Distribution
		- No significant variation
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
		- Endolymph accumulation -> Increased pressure -> Disrupts vestibular & cochlear function (*Hair cell disfunction*)
		- Possible membrane ruptures -> Potassium toxicity to hair cells
	- ### Affected Systems/Organs
		- Inner ear (cochlea & vestibular system)
- ## Clinical Features
  background-color:: blue
	- ### Clinical Presentation
		- #### Symptoms
			- Episodic vertigo (20 min-24 hrs)
			- Fluctuating hearing loss (low frequency initially)
			- Tinnitus (roaring/buzzing)
			- Aural fullness
		- #### Signs
			- Otoscopy : Normal Tympanic Membrane
			- Tuning fork tests
				- |Test|Finding|
				  |--|--|
				  |Rinne's Test|Positive(SNHL)|
				  |Weber's Test|Lateralized to better ear|
				  |Absolute Bone Conduction(ABC) test|Decreased|
			-
	- ### Stages or Classification
		- Early : Episodic verigo + hearing fluctuations
		- Middle : Persistent hearing loss + severe vertigo
		- Late : Permanent hearing loss + chronic imbalance
	- ### Diagnostic Criteria
- ## Diagnosis #ent-prof-card #unanswered #card
  background-color:: blue
  deck:: #ENT
  id:: cacace2a-0212-4b4f-8198-80c2164bb44f
	- ### Diagnostic Criteria
	  *AAO-HNS 2015*
		- ≥2 vertigo episodes (20 min-12 hours)
		- Audiometric SNHL
		- Tinnitus/aural fullness
	- ### Investigations
		- Pure tone audiometry : Low frequency Sensinoneuronal deafness
		- Electrocochleaography : ↑ SP/AP ratio
		- Glycerol dehyration test
		- caloric test
	- ### Differential Diagnosis
		- ### Ruling Out Differential Diagnosis
			- |DD|Ruling Out|
			  |--|--|
			  |Vestibular migraine|No hearing loss, features of migraine|
			  |BPPV(MPPV variant)|Brief vertigo(<1 min), Positional, Dix-Hallpike +ve|
			  |Labyrinthitis| Sudden vertigo + viral URI history, MRI(if bacterial)|
			  |Acoustic neuroma | imbalance but no vertigo, MRI with contrast |
			  |Otosyphilis| Bilateral SNHL + systemic signs, RPR|
	- ### Confirmation of Diagnosis
- ## Management and Treatment #ent-prof-card #ent-prof-written  #card
  background-color:: blue
  id:: 3abf9902-4436-4be6-ad4c-1ad09cab3a65
  deck:: #ENT
	- ### Medical Treatment
		- Acute attacks
			- Vestibular suppressants (diazepam, meclizine)
			- Antiemetics (ondansetron)
		- Prophylaxis
			- Diuretics (hydrochlorthiazide)
			- Betahistine (controversial)
			- Steroids (oral/intratympanic)
	- ### Surgical Options
	  *Refractory cases*
		- Placebo Surgery : Myringotomy with Gromet insertion
		- Endolymphatic sac decompression
		- Gentamicin ablation (chemical labyrinthectomy)
		- Vestibular neurectomy
	- ### Lifestyle and Dietary Recommendations
		- Low-salt diet (<2g/day)
		- Avoid caffeine/alcohol
		- Stress management
	- ### Follow-up
		- Audiometry & vestibular testing every 6-12 months
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment
			- Symptoms controlled in ~70%
		- #### Without Treatment
			- ##### Possible Complications
				- Progressive hearing loss
			- ##### Long-Term Effects
				- Chronic Imbalance
	- ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
	- Avoid triggers (salt, stress, caffeine)
	- Early intervention
	- ### Health Education
	- ### Community Approach
	- ### Screening Programs
	- ### Lifestyle Modifications
- ## Patient Education and Support
  background-color:: blue
	- Vestibular rehab therapy(VRT)
	- ### Educational Resources
	- ### Support Groups
		- Ménière’s Society support groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
		- Gene therapy trials
		- Novel inner ear drug delivery systems
	- ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue
- #SN Short Note #ent-prof-written #unanswered #card
  deck:: #ENT
  id:: 675800ff-fe62-48ff-98ef-df6ef1e4aa43